Premium
Use of the PD ‐1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy
Author(s) -
Boils C. L.,
Aljadir D. N.,
Cantafio A. W.
Publication year - 2016
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.13786
Subject(s) - medicine , nivolumab , malignancy , gastroenterology , cancer , urology , immunotherapy